Home › Mood Disorders › Washington
Mood Disorders clinical trials in Washington
3 studies for Mood Disorders are looking for participants at sites in Washington.
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Everett
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Nov 10, 2026 · NCT07065240A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 4, 2026 · NCT07412756A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 3, 2026 · NCT07775300From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.